Concept of natural genome reconstruction. Part 5. Analysis of changes in the lifespan of old animals after reinfusion of bone marrow cells derived from old animals and treated with hDNAgr in combination with recombinant human angiogenin

Two series of tests were performed, on mice and rats, to assess the lifespan of old animals reinfused with bone marrow cells from old animals treated with fragmented human DNA (hDNAgr), recombinant human angiogenin, and both preparations together. Animals reinfused with untreated bone marrow cells from old animals or bone marrow cells from young animals were used as comparison groups. Using both outbred mice and CBA/Lac mice, no significant increase in the lifespan of animals reinfused with bone marrow cells treated with the hDNAgr was found compared with the group of mice reinfused with untreated bone marrow cells. Using the CBA/Lac line, mice reinfused with bone marrow cells treated with angiogenin simultaneously died of the characteristic symptom complex at 10 months after treatment. Pathomorphological analysis suggests that the simultaneous death of mice occurred as a result of pathological disorders in the excretory systems of animals. Reinfusion of bone marrow cells from old animals treated with angiogenin and hDNAgr and bone marrow cells taken from young animals significantly increases the lifespan of mice in groups. The combined use of two activators, angiogenin and hDNAgr, increased the average lifespan of 30 % of experimental mice to 35 months compared to 28 months in the control. Using Wistar rats as model animals in the first experiment, a reliable increase in the lifespan of rats with reinfusion of bone marrow cells from old animals treated with the hDNAgr preparation to 28 months was shown compared to the group that received untreated bone marrow cells from old animals, where the average lifespan of rats was 24 months. In the second similar experiment, no reliable difference in the lifespan of rats for the two groups was shown. Animals injected with bone marrow cells treated with angiogenin lived significantly longer than rats from the control group. The analysis of the amount of telomeric DNA in bone marrow cells of rats from the experimental and control groups 12 months after treatment showed that there was no significant increase in telomeric DNA. A molecular/cellular model of aging of the organism associated with the concept of “natural reconstruction of the genome” is considered.

1. Aubert G., Lansdorp P.M. Telomeres and aging. Physiol Rev. 2008; 88(2):557-579. doi 10.1152/physrev.00026.2007

2. Bernardes de Jesus B., Vera E., Schneeberger K., Tejera A.M., Ayuso E., Bosch F., Blasco M.A. Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer. EMBO Mol Med. 2012;4(8):691-704. doi 10.1002/emmm.201200245

3. Bowen R.L., Atwood C.S. Living and dying for sex. A theory of aging based on the modulation of cell cycle signaling by reproductive hormones. Gerontology. 2004;50(5):265-290. doi 10.1159/000079125

4. Brooks R.W., Robbins P.D. Treating age-related diseases with somatic stem cells. In: Mettinger K., Rameshwar P., Kumar V. (Eds) Exosomes, Stem Cells and MicroRNA. Advances in Experimental Medicine and Biology. Vol. 1056. Springer, 2018;29-45. doi 10.1007/978-3-319-74470-4_3

5. Chakravarti D., LaBella K.A., DePinho R.A. Telomeres: history, health, and hallmarks of aging. Cell. 2021;184(2):306-322. doi 10.1016/j.cell.2020.12.028

6. da Costa J.P., Vitorino R., Silva G.M., Vogel C., Duarte A.C., RochaSantos T. A synopsis on aging – theories, mechanisms and future prospects. Ageing Res Rev. 2016;29:90-112. doi 10.1016/j.arr.2016.06.005

7. Davidsohn N., Pezzone M., Vernet A., Graveline A., Oliver D., Slomovic S., Punthambaker S., Sun X., Liao R., Bonventre J.V., Church G.M. A single combination gene therapy treats multiple age-related diseases. Proc Natl Acad Sci USA. 2019;116(47):2350523511. doi 10.1073/pnas.1910073116

8. Di Micco R., Krizhanovsky V., Baker D., d’Adda di Fagagna F. Cellular senescence in ageing: from mechanisms to therapeutic opportunities. Nat Rev Mol Cell Biol. 2021;22(2):75-95. doi 10.1038/S41580-020-00314-w

9. Doksani Y. The response to DNA damage at telomeric repeats and its consequences for telomere function. Genes. 2019;10(4):318. doi 10.3390/genes10040318

10. Dolgova E.V., Nikolin V.P., Popova N.A., Proskurina A.S., Orishenko K.E., Alyamkina E.A., Efremov Y.R., … Taranov O.S., Rogachev V.A., Sidorov S.V., Bogachev S.S., Shurdov M.A. Internalization of exogenous DNA into internal compartments of murine bone marrow cells. Russ J Genet Appl Res. 2012;2:440-452. doi 10.1134/S2079059712060056

11. Gems D., Partridge L. Genetics of longevity in model organisms: debates and paradigm shifts. Annu Rev Physiol. 2013;75:621-644. doi 10.1146/annurev-physiol-030212-183712

12. Gowing G., Svendsen S., Svendsen C.N. Ex vivo gene therapy for the treatment of neurological disorders. Prog Brain Res. 2017;230:99132. doi 10.1016/bs.pbr.2016.11.003

13. Hande M.P. DNA repair factors and telomere-chromosome integrity in mammalian cells. Cytogenet Genome Res. 2004;104(1-4):116-122. doi 10.1159/000077475

14. Harley C.B., Futcher A.B., Greider C.W. Telomeres shorten during ageing of human fibroblasts. Nature. 1990;345(6274):458-460. doi 10.1038/345458a0

15. He S., Sharpless N.E. Senescence in health and disease. Cell. 2017; 169(6):1000-1011. doi 10.1016/j.cell.2017.05.015

16. Hong J., Yun C.O. Telomere gene therapy: polarizing therapeutic goals for treatment of various diseases. Cells. 2019;8(5):392. doi 10.3390/cells8050392

17. Kenyon C.J. The genetics of ageing. Nature. 2010;464(7288):504-512. doi 10.1038/nature08980

18. Kirkwood T.B.L. Understanding the odd science of aging. Cell. 2005; 120(4):437-447. doi 10.1016/j.cell.2005.01.027

19. Kozlov A.A. Old age: social disunity or integrity? Theories and traditions of Western social psychology. Mir Psikhologii: NauchnoMetodicheskiy Zhurnal = World of Psychology: Research and Methodological Journal. 1999;2:80-96 (in Russian)

20. Krauss S.R., de Haan G. Epigenetic perturbations in aging stem cells. Mamm Genome. 2016;27(7-8):396-406. doi 10.1007/s00335-0169645-8

21. Lefever R. The rehabilitation of irreversible processes and dissipative structures’ 50th anniversary. Philos Trans A Math Phys Eng Sci. 2018;376(2124):20170365. doi 10.1098/rsta.2017.0365

22. Li Y., Zhou G., Bruno I.G., Cooke J.P. Telomerase mRNA reverses senescence in progeria cells. J Am Coll Cardiol. 2017;70(6):804-805. doi 10.1016/j.jacc.2017.06.017

23. Loe T.K., Li J.S.Z., Zhang Y., Azeroglu B., Boddy M.N., Denchi E.L. Telomere length heterogeneity in ALT cells is maintained by PMLdependent localization of the BTR complex to telomeres. Genes Dev. 2020;34(9-10):650-662. doi 10.1101/gad.333963.119

24. López-Otín C., Blasco M.A., Partridge L., Serrano M., Kroemer G. The hallmarks of aging. Cell. 2013;153(6):1194-1217. doi 10.1016/j.cell.2013.05.039

25. López-Otín C., Blasco M.A., Partridge L., Serrano M., Kroemer G. Hallmarks of aging: an expanding universe. Cell. 2023;186(2):243278. doi 10.1016/j.cell.2022.11.001

26. Lundblad V. Telomere maintenance without telomerase. Oncogene. 2002;21(4):522-531. doi 10.1038/sj.onc.1205079

27. Maniatis T., Fritch E., Sambrook D. Methods of Genetic Engineering. Molecular Cloning. Moscow: Mir Publ., 1984 (in Russian) Mikheev R.K., Andreeva E.N., Grigoryan O.R., Sheremetyeva E.V., Absatarova Y.S., Odarchenko A.S., Opletaeva O.N. Molecular and cellular mechanisms of ageing: modern knowledge (literature review). Problems of Endocrinology. 2023;69(5):45-54. doi 10.14341/probl13278 (in Russian)

28. Nabetani A., Ishikawa F. Alternative lengthening of telomeres pathway: recombination-mediated telomere maintenance mechanism in human cells. J Biochem. 2011;149(1):5-14. doi 10.1093/jb/mvq119

29. Nassour J., Radford R., Correia A., Fusté J.M., Schoell B., Jauch A., Shaw R.J., Karlseder J. Autophagic cell death restricts chromosomal instability during replicative crisis. Nature. 2019;565:659-663. doi 10.1038/S41586-019-0885-0

30. Ocampo A., Reddy P., Martinez-Redondo P., Platero-Luengo A., Hatanaka F., Hishida T., Li M., … Nuñez Delicado E., Campistol J.M., Guillen I., Guillen P., Izpisua Belmonte J.C. In vivo amelioration of age-associated hallmarks by partial reprogramming. Cell. 2016; 167(7):1719-1733.e12. doi 10.1016/j.cell.2016.11.052

31. Pickett H.A., Cesare A.J., Johnston R.L., Neumann A.A., Reddel R.R. Control of telomere length by a trimming mechanism that involves generation of t-circles. EMBO J. 2009;28(7):799-809. doi 10.1038/emboj.2009.42

32. Proshkina E.N., Solovev I.A., Shaposhnikov M.V., Moskalev A.A. Key molecular mechanisms of aging, biomarkers, and potential interventions. Mol Biol. 2020;54(6):777-811. doi 10.1134/S0026893320060096

33. Rossiello F., Jurk D., Passos J.F., d’Adda di Fagagna F. Telomere dysfunction in ageing and age-related diseases. Nat Cell Biol. 2022; 24(2):135-147. doi 10.1038/s41556-022-00842-x

34. Rovatsos M.T., Marchal J.A., Romero-Fernández I., Fernández F.J., Giagia-Athanosopoulou E.B., Sánchez A. Rapid, independent, and extensive amplification of telomeric repeats in pericentromeric regions in karyotypes of arvicoline rodents. Chromosome Res. 2011; 19(7):869-882. doi 10.1007/S10577-011-9242-3

35. Ruzanova V.S., Oshikhmina S.G., Ritter G.S., Dolgova E.V., Kirikovich S.S., Levites E.V., Efremov Y.R., Karamysheva T.V., Bogomolov A.G., Meschaninova M.I., Mamaev A.L., Taranov O.S., Sidorov S.V., Nikonov S.D., Leplina O.Y., Ostanin A.A., Chernykh E.R., Kolchanov N.A., Proskurina A.S., Bogachev S.S. Concept of natural genome reconstruction. Part 3. Analysis of changes in the amount of telomeric DNA in colony cells as a new amplified feature that arose during the processing of hematopoietic bone marrow stem cells. Vavilovskii Zhurnal Genetiki i Selektsii = Vavilov J Genet Breed. 2025; 29(4):479-495. doi 10.18699/vjgb-25-52

36. Sogabe Y., Seno H., Yamamoto T., Yamada Y. Unveiling epigenetic regulation in cancer, aging, and rejuvenation with in vivo reprogramming technology. Cancer Sci. 2018;109(9):2641-2650. doi 10.1111/cas.13731

37. Stein G.H., Drullinger L.F., Soulard A., Dulić V. Differential roles for cyclin-dependent kinase inhibitors p21 and p16 in the mechanisms of senescence and differentiation in human fibroblasts. Mol Cell Biol. 1999;19(3):2109-2117. doi 10.1128/mcb.19.3.2109

38. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126(4):663-676. doi 10.1016/j.cell.2006.07.024

39. Tchkonia T., Zhu Y., van Deursen J., Campisi J., Kirkland J.L. Cellular senescence and the senescent secretory phenotype: therapeutic opportunities. J Clin Invest. 2013;123(3):966-972. doi 10.1172/jci64098

40. Tlidi M., Clerc M.G., Panajotov K. Dissipative structures in matter out of equilibrium: from chemistry, photonics and biology, the legacy of Ilya Prigogine (part 1). Philos Trans A Math Phys Eng Sci. 2018a; 376(2124):20180114. doi 10.1098/rsta.2018.0114

41. Tlidi M., Clerc M.G., Panajotov K. Dissipative structures in matter out of equilibrium: from chemistry, photonics and biology, the legacy of Ilya Prigogine (part 2). Philos Trans A Math Phys Eng Sci. 2018b; 376(2135):20180276. doi 10.1098/rsta.2018.0276

42. Vaiserman A.M., Lushchak O.V., Koliada A.K. Anti-aging pharmacology: promises and pitfalls. Ageing Res Rev. 2016;31:9-35. doi 10.1016/j.arr.2016.08.004

43. Vijg J., Campisi J. Puzzles, promises and a cure for ageing. Nature. 2008;454(7208):1065-1071. doi 10.1038/nature07216

44. Zhu X., Chen Z., Shen W., Huang G., Sedivy J.M., Wang H., Ju Z. Inflammation, epigenetics, and metabolism converge to cell senescence and ageing: the regulation and intervention. Signal Transduct Target Ther. 2021;6(1):245. doi 10.1038/S41392-021-00646-9